Health Care·Health Care Equipment·$48.5B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.78 | N/A | +2.63% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.78 | N/A | +2.63% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Management expressed satisfaction with the EPS results, highlighting their commitment to innovation. They emphasized the importance of addressing patient needs in their future strategies.
We are pleased with our EPS performance this quarter.
Our focus remains on innovation and meeting patient needs.
Edwards Lifesciences reported a better-than-expected EPS, which contributed to a slight increase in their stock price. Investors may view the positive EPS surprise as a sign of resilience in the company's performance. However, the lack of revenue data and guidance leaves some uncertainty about future growth prospects.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
STRATEGY INC A
Feb 2, 2009